CIRS Receives $1.09M from Bill & Melinda Gates Foundation to continue their Philanthropic Services.


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ CIRS Receives $1.09M from Bill & Melinda Gates Foundation to continue their Philanthropic Services
Centre for Innovation in Regulatory Science Awarded a $1.09m Grant to Help Accelerate Registration of Medicines in Low and Middle Income Countries

The Centre for Innovation in Regulatory Science (CIRS), a neutral and independent, international member-based organisation headquartered in the UK, has been awarded a phase two grant of $1.09m by the Bill & Melinda Gates Foundation to continue their collaborative endeavours to expedite patient access to medicines in specific areas of greatest medical need in Low and Middle Income Countries.

The grant has been awarded to CIRS for the purpose of 'Tracking Regulatory Performance Metrics in Low and Middle Income Countries' to accelerate and consolidate the activities around a unique metrics collection programme which aims to assist LMICs achieve targeted improvements in regulatory performance goals and ultimately, to accelerate registration of quality medicines in these countries.

Regulators in LMICs strive to develop fit-for-purpose regulatory systems, in particular, those related to the review, assessment and approval of medicines, including vaccines. Inefficiencies, especially redundancies, in the process can translate into long and unpredictable review times for medicines, resulting in delays to their registration. These inefficiencies can also affect the authorisation of competitive generic and biosimilar products, which has an impact on the costs and availability of many medicines.

CIRS has collected regulatory marketing authorisation assessment data for more than 20 years, especially in high-income countries, and has developed a standardised reporting approach to identify key characteristics that may impact regulatory performance to allow accurate interpretation of the metrics being evaluated. With such data, regulatory authorities have been able to continually improve their performance against their own goals and against the performance of peer agencies.

Through CIRS' OpERA programme (Optimising Efficiencies in Regulatory Agencies) it combines qualitative and quantitative information to provide a detailed picture of the regulatory assessment activities of agencies at any stage of maturity and provides each country with a country report which permits global comparisons to similar agencies and encourages the sharing and adoption of good review practices.

The grant will also allow CIRS to provide opportunities for emerging national regulatory agencies to come together at regional forums in Africa, Latin America, and Asia during the three years of the grant. The sharing of experiences is a key way that regulators identify important new ways to improve their organisational efficiency and learn about tools and processes that will help build best regulatory assessment practices.

Jamie Munro, Executive Director, CIRS said: "The efficient, predictable, and speedy assessment and introduction of quality new medicines and vaccines to underserved patient populations continues to be a priority for the whole healthcare community. The aims of phase two of this programme are to give regulatory agencies in LMICs the tools and information to measure themselves against the outcomes of their evolving product assessment processes; whilst transitioning the OpERA programme to a financially self-sustainable performance metric monitoring system for the ongoing use of participating agencies."

Africa: Ethiopia, East African Community (EAC), Zazibona initiative (in particular, the original members: Zambia, Zimbabwe, Botswana & Namibia), West Africa Health Organisation (WAHO – in particular Ghana, Nigeria, Burkina Faso & Senegal) and the South African Health Products Regulatory Authority (SAHPRA).

Latin America: Brazil, Mexico, Peru, Haiti, CARICOM (Caribbean Community).

Asia/Middle East: India, Indonesia, Vietnam, Malaysia, Philippines, Singapore, Thailand, China, Gulf Health Council (GHC).

Tags : #Centreforinnovationinregulatoryscience #Billandmelindagatesfoundation #Patientaccess

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026